# The Medicines for Human Use (Clinical Trials) Regulations 2004, Paragraph 14Q


The holder of a manufacturing authorisation (POC) shall ensure that—
(a) the requirements of paragraphs 1 to 14 and 14K to 14P are complied with in relation to manufacturing carried out at the POC (IMP) sites specified in the POC (IMP) master file;
(b) only the POC investigational medicinal products specified in the authorisation are manufactured or assembled at those sites; and
(c) a POC investigational medicinal product specified in the authorisation is only manufactured at a POC (IMP) site specified in the POC (IMP) master file.

---
Source: https://www.legislation.gov.uk/uksi/2004/1031/schedule/7/paragraph/14Q (the official version)
Page: https://openlegislation.uk/medicines-for-human-use-clinical-trials-regulations-2004/schedule-7/paragraph-14Q
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.